Total Payments
$19,225
2024 Payments
$2,618
Companies
12
Transactions
34
Medicare Patients
682
Medicare Billing
$130,214
Payment Breakdown by Category
Consulting$16,626 (86.5%)
Food & Beverage$1,283 (6.7%)
Travel$1,271 (6.6%)
Education$45.12 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,626 | 7 | 86.5% |
| Food and Beverage | $1,283 | 20 | 6.7% |
| Travel and Lodging | $1,271 | 5 | 6.6% |
| Education | $45.12 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $7,863 | 15 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $3,485 | 3 | $0 (2023) |
| Daiichi Sankyo Inc. | $2,820 | 3 | $0 (2024) |
| GENZYME CORPORATION | $2,268 | 1 | $0 (2021) |
| Mirati Therapeutics, Inc. | $2,188 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $149.76 | 1 | $0 (2023) |
| Regeneron Pharmaceuticals, Inc. | $147.83 | 1 | $0 (2023) |
| AstraZeneca UK Limited | $135.00 | 1 | $0 (2024) |
| Agile Therapeutics, Inc. | $64.90 | 4 | $0 (2024) |
| Genentech USA, Inc. | $46.49 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,618 | 7 | Daiichi Sankyo Inc. ($2,350) |
| 2023 | $6,395 | 10 | E.R. Squibb & Sons, L.L.C. ($3,335) |
| 2022 | $26.77 | 2 | Agile Therapeutics, Inc. ($14.83) |
| 2021 | $2,268 | 1 | GENZYME CORPORATION ($2,268) |
| 2019 | $7,917 | 14 | AstraZeneca Pharmaceuticals LP ($7,767) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $940.00 | General |
| 10/23/2024 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $1,410.00 | General |
| 09/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $51.31 | General |
| 06/05/2024 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 06/02/2024 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $135.00 | General |
| 06/02/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $46.49 | General |
| 03/26/2024 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 12/01/2023 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $147.83 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2023 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $31.20 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2023 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $13.92 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2023 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,150.00 | General |
| 10/03/2023 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $470.00 | General |
| 08/28/2023 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 07/12/2023 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $149.76 | General |
| Category: Oncology | ||||||
| 06/04/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $44.99 | General |
| 06/02/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Consulting Fee | Cash or cash equivalent | $2,187.50 | General |
| Category: ONCOLOGY | ||||||
| 03/02/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $184.62 | General |
| 11/10/2022 | Integra LifeSciences Corporation | BIOFIX (Device), BIODRESTORE, BIODFACTOR | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Othobio | ||||||
| 10/25/2022 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 10/27/2021 | GENZYME CORPORATION | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $2,268.00 | General |
| Category: Oncology | ||||||
| 06/25/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| 05/27/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $6,200.00 | General |
| Category: Oncology | ||||||
| 04/26/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $488.80 | General |
| Category: Oncology | ||||||
| 04/26/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $257.11 | General |
| Category: Oncology | ||||||
| 04/26/2019 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Travel and Lodging | In-kind items and services | $227.50 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 128 | 338 | $101,793 | $26,990 |
| 2022 | 4 | 130 | 247 | $74,577 | $22,818 |
| 2021 | 4 | 176 | 393 | $120,233 | $36,742 |
| 2020 | 6 | 248 | 561 | $151,394 | $43,664 |
Total Patients
682
Total Services
1,539
Medicare Billing
$130,214
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 236 | $72,888 | $18,088 | 24.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 46 | $17,438 | $5,293 | 30.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 18 | 31 | $4,787 | $2,307 | 48.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 25 | $6,680 | $1,302 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 143 | $43,329 | $11,478 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 31 | 54 | $20,142 | $6,453 | 32.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 30 | 38 | $5,814 | $3,080 | 53.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $5,292 | $1,808 | 34.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 51 | 140 | $52,220 | $17,228 | 33.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 76 | 188 | $56,964 | $15,676 | 27.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 31 | 46 | $7,038 | $3,652 | 51.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2021 | 18 | 19 | $4,011 | $185.13 | 4.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 83 | 247 | $79,843 | $22,528 | 28.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 66 | 157 | $24,021 | $10,222 | 42.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 56 | 113 | $32,691 | $7,268 | 22.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 19 | 19 | $7,135 | $2,480 | 34.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 12 | 12 | $3,648 | $1,023 | 28.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 12 | 13 | $4,056 | $142.21 | 3.5% |
About Dr. Hina Khan, M.D
Dr. Hina Khan, M.D is a Hematology & Oncology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2010. The National Provider Identifier (NPI) number assigned to this provider is 1356662803.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hina Khan, M.D has received a total of $19,225 in payments from pharmaceutical and medical device companies, with $2,618 received in 2024. These payments were reported across 34 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($16,626).
As a Medicare-enrolled provider, Khan has provided services to 682 Medicare beneficiaries, totaling 1,539 services with total Medicare billing of $130,214. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Providence, RI
- Active Since 06/18/2010
- Last Updated 07/18/2016
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1356662803
Products in Payments
- TAGRISSO (Drug) $7,767
- LIBTAYO (Biological) $2,416
- KRAZATI (Drug) $2,188
- RYBREVANT (Drug) $149.76
- Twirla (Drug) $64.90
- IBRANCE (Drug) $45.12
- BIOFIX (Device) $11.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Providence
Ritesh Rathore, Md, MD
Hematology & Oncology — Payments: $324,296
Hematology & Oncology $324,296
Anthony Mega, Md, MD
Hematology & Oncology — Payments: $193,307
Hematology & Oncology $193,307
Dr. Adam Olszewski, M.d, M.D
Hematology & Oncology — Payments: $47,507
Hematology & Oncology $47,507
John Reagan, Md, MD
Hematology & Oncology — Payments: $35,520
Hematology & Oncology $35,520
Dr. Joseph Dibenedetto, Md, MD
Hematology & Oncology — Payments: $6,205
Hematology & Oncology $6,205
Robert Sokolic, M.d, M.D
Hematology & Oncology — Payments: $5,699
Hematology & Oncology $5,699